The increase in PAF and TNF-α 12 weeks after the diagnosis of GDM could be useful in the future for monitoring this condition and potentially help to explain the hidden mechanisms behind metabolic and inflammatory interactions in GDM. This evidence concerns the gene PCLAF and gestational diabetes.